Population
Subjects with familial combined hyperlipidemia, monogenic familial hypertriglyceridemia, and normal control…
Design
Cross-sectional
Authors
Loading...
Supports distinct entities in hypertriglyceridemia subtypes; leaves open effects on risk stratification or therapy.
Familial combined hyperlipidemia and monogenic familial hypertriglyceridemia exhibit distinct lipoprotein composition and size profiles, supporting that they are distinct pathological entities.
Brunzell et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: